Table 2.
Prevalence of ACE inhibitor and Statin Medication Use, Dose and Duration Over Time
| Medication Use | Year 1 n=3055 % |
Year 2 n=2911 % |
Year 3 n=2693 % |
Year 5 n=2480 % |
Year 6 n=2327 % |
|---|---|---|---|---|---|
| Any ACEI use | 15.2 | 16.7 | 18.3 | 23.5 | 25.6 |
| High dose (> 2 SDD) | 2.4 | 2.7 | 3.5 | 5.0 | 6.4 |
| Medium dose (1–2 SDD) | 10.0 | 11.4 | 11.7 | 15.2 | 16.1 |
| Low dose (<1.0 SDD) | 2.8 | 2.7 | 3.0 | 3.3 | 3.1 |
| Long term use (≥2 years) | 8.8 | 12.7 | 14.3 | 15.0 | 20.7 |
| Short term use (<2 years) | 6.4 | 4.0 | 3.9 | 8.5 | 5.0 |
| Any Statin use | 12.9 | 15.8 | 19.9 | 25.2 | 28.6 |
| High dose (> 1 SDD) | 1.2 | 2.4 | 3.6 | 6.5 | 8.3 |
| Medium dose (1 SDD) | 4.0 | 5.7 | 7.8 | 11.7 | 12.9 |
| Low dose (<1.0 SDD) | 7.8 | 7.8 | 8.5 | 7.0 | 7.5 |
| Long term use (≥2 years) | 5.9 | 11.3 | 14.6 | 17.3 | 23.5 |
| Short term use (<2 years) | 7.0 | 4.5 | 5.3 | 7.9 | 5.2 |
Abbreviations: ACE=angiotensin-converting enzymer; SDD=standardized daily dose